Mounjaro®
Starting from £179.99/mo
Start journey Learn moreNausea, loose stools and indigestion sit at the top of the list when it comes to the most common side effects of Mounjaro. Most people notice them in the first few weeks of treatment or after a dose increase, and for the majority they ease off as the body adjusts. Mounjaro (tirzepatide) is a prescription-only medicine — a prescriber assesses whether it is clinically suitable for you before any treatment begins, and understanding its side-effect profile is part of that conversation. This page covers what the NHS's tirzepatide medicine page and the clinical evidence describe: which effects are common, which need prompt medical attention, and how to tell the difference.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most commonly reported Mounjaro side effects are digestive in nature. Nausea leads the list as the most common side effect of Mounjaro, followed by vomiting, diarrhoea, constipation and reflux or indigestion. Burping and a general feeling of fullness that arrives quickly during meals are also frequently mentioned. Headache, dizziness and tiredness round out the picture for some people.
There is a straightforward reason the gut takes the brunt. Tirzepatide slows the speed at which the stomach empties, which is part of how it reduces appetite. That same slowing can make the digestive system feel unsettled, particularly while it is adapting. Effects tend to be most noticeable in the first one to two weeks after starting treatment or after moving to a higher dose, and they often reduce significantly once the body has adjusted. Not everyone experiences them, and the severity varies widely. A full breakdown of Mounjaro side effects across the dose schedule covers how rates shift as treatment progresses.
One thing worth setting straight: a common assumption is that nausea means the medicine is not working, or that pushing through without any discomfort means it is. Neither is reliable. Side-effect experience tells you about your individual tolerability, not about how much weight you will lose.
Beyond the GI symptoms, some people on Mounjaro notice injection-site reactions, redness, mild swelling or itching where the pen was used. Rotating between the abdomen, thigh and upper arm and using a fresh site each week helps. Heartburn, stomach pain (distinct from the severe kind described below) and reduced appetite beyond what is expected are also reported.
Hair thinning occasionally comes up. It tends to reflect the effect of rapid weight loss on the hair cycle rather than a direct effect of the medicine itself, and is typically temporary. If this is a concern, the page on hair loss on Mounjaro goes into the evidence in detail.
Headache is worth a separate note: it often tracks with reduced food and fluid intake in the early weeks. Staying well hydrated and maintaining adequate protein can help. For those wondering about timing, there is specific guidance on how long Mounjaro headache typically lasts based on what the data shows.
For a fuller picture of how frequently each side effect occurs across the population, the rates and frequency data for tirzepatide side effects are worth reading alongside this page.
Most Mounjaro side effects are manageable and temporary. A smaller number are serious and require prompt attention. Know these.
Severe, persistent abdominal pain (particularly pain that spreads to the back, with or without vomiting) may indicate acute pancreatitis. In January 2026, following a review of reported cases, the MHRA issued a Drug Safety Update confirming acute pancreatitis as a known, infrequent but serious risk associated with GLP-1 medicines including tirzepatide. Do not try to wait this out. Call NHS 111 or go to A&E if you experience it.
Other situations that warrant same-day medical contact: signs of a severe allergic reaction (swelling of the face, throat or tongue, difficulty breathing, rapid heartbeat); symptoms of gallbladder problems (sharp pain in the upper right abdomen, especially after eating fatty food); and signs of significant dehydration following severe vomiting or diarrhoea, reduced urination, confusion, or feeling faint. If you are experiencing concerning symptoms and are a nume patient, our aftercare team is available seven days a week through the contact page.
If you suspect a side effect from Mounjaro, reporting it through the Yellow Card scheme at yellowcard.mhra.gov.uk helps the MHRA build a clearer safety picture for everyone using this medicine.
Tirzepatide's side-effect profile is well-characterised from the SURMOUNT-1 trial and subsequent real-world experience. Most of the practical measures that help are simple. Eating smaller portions more slowly, avoiding very fatty or heavily spiced food in the first weeks, and drinking enough water throughout the day all reduce GI burden. Taking the injection on the same day each week helps maintain a stable rhythm.
The dose schedule itself is designed with tolerability in mind. Treatment begins at 2.5mg (the starter dose exists specifically to let the body adjust before any therapeutic increase) and moves up in steps guided by the prescriber. Rushing the titration is one of the more reliable ways to make side effects worse. That schedule is always set by your prescriber, not by the patient alone, and the common side effects of tirzepatide at each stage are discussed as part of that ongoing clinical relationship.
If you are considering Mounjaro and want to understand what to expect before committing, our clinical team can answer questions specific to your health history. The free consultation is the starting point, a GPhC-registered prescriber reads your answers, not software, and eligibility and side effects are covered as standard.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.